192 related articles for article (PubMed ID: 22462645)
1. Recent advances in the pathophysiology and pharmacological treatment of obesity.
Chugh PK; Sharma S
J Clin Pharm Ther; 2012 Oct; 37(5):525-35. PubMed ID: 22462645
[TBL] [Abstract][Full Text] [Related]
2. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
Bays H
Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
[TBL] [Abstract][Full Text] [Related]
3. New and emerging drug molecules against obesity.
George M; Rajaram M; Shanmugam E
J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):65-76. PubMed ID: 24064009
[TBL] [Abstract][Full Text] [Related]
4. Emerging pharmacotherapy for obesity.
Aronne LJ; Powell AG; Apovian CM
Expert Opin Emerg Drugs; 2011 Sep; 16(3):587-96. PubMed ID: 21834735
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapeutic options for overweight adolescents.
Dunican KC; Desilets AR; Montalbano JK
Ann Pharmacother; 2007 Sep; 41(9):1445-55. PubMed ID: 17652127
[TBL] [Abstract][Full Text] [Related]
6. New drug targets for the treatment of obesity.
Powell AG; Apovian CM; Aronne LJ
Clin Pharmacol Ther; 2011 Jul; 90(1):40-51. PubMed ID: 21654742
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological therapies for obesity.
Kaplan LM
Gastroenterol Clin North Am; 2005 Mar; 34(1):91-104. PubMed ID: 15823441
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy for weight loss: the cardiovascular effects of the old and new agents.
Walter CP; Bleske BE; Dorsch MP
J Clin Pharm Ther; 2014 Oct; 39(5):475-84. PubMed ID: 24924286
[TBL] [Abstract][Full Text] [Related]
9. An update on the pharmacological treatment of obesity.
Schnee DM; Zaiken K; McCloskey WW
Curr Med Res Opin; 2006 Aug; 22(8):1463-74. PubMed ID: 16870072
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy for obesity.
Ioannides-Demos LL; Proietto J; McNeil JJ
Drugs; 2005; 65(10):1391-418. PubMed ID: 15977970
[TBL] [Abstract][Full Text] [Related]
11. Drug safety evaluation of naltrexone/bupropion for the treatment of obesity.
Verpeut JL; Bello NT
Expert Opin Drug Saf; 2014 Jun; 13(6):831-41. PubMed ID: 24766397
[TBL] [Abstract][Full Text] [Related]
12. A critical review of the cannabinoid receptor as a drug target for obesity management.
Akbas F; Gasteyger C; Sjödin A; Astrup A; Larsen TM
Obes Rev; 2009 Jan; 10(1):58-67. PubMed ID: 18721231
[TBL] [Abstract][Full Text] [Related]
13. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
Roth JD; Trevaskis JL; Wilson J; Lei C; Athanacio J; Mack C; Kesty NC; Coffey T; Weyer C; Parkes DG
Int J Obes (Lond); 2008 Aug; 32(8):1201-10. PubMed ID: 18560368
[TBL] [Abstract][Full Text] [Related]
14. New approaches to the pharmacological treatment of obesity: can they break through the efficacy barrier?
Kennett GA; Clifton PG
Pharmacol Biochem Behav; 2010 Nov; 97(1):63-83. PubMed ID: 20688100
[TBL] [Abstract][Full Text] [Related]
15. Anti-obesity drugs: a review about their effects and their safety.
Derosa G; Maffioli P
Expert Opin Drug Saf; 2012 May; 11(3):459-71. PubMed ID: 22439841
[TBL] [Abstract][Full Text] [Related]
16. Drug strategies for the treatment of obesity.
Alemany M; Remesar X; Fernández-López JA
IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679
[TBL] [Abstract][Full Text] [Related]
17. Role of metformin for weight management in patients without type 2 diabetes.
Desilets AR; Dhakal-Karki S; Dunican KC
Ann Pharmacother; 2008 Jun; 42(6):817-26. PubMed ID: 18477733
[TBL] [Abstract][Full Text] [Related]
18. Current and future drug targets in weight management.
Witkamp RF
Pharm Res; 2011 Aug; 28(8):1792-818. PubMed ID: 21181547
[TBL] [Abstract][Full Text] [Related]
19. Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women.
Gadde KM; Parker CB; Maner LG; Wagner HR; Logue EJ; Drezner MK; Krishnan KR
Obes Res; 2001 Sep; 9(9):544-51. PubMed ID: 11557835
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy of obesity: emerging drugs and targets.
Chakrabarti R
Expert Opin Ther Targets; 2009 Feb; 13(2):195-207. PubMed ID: 19236237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
